Loading stock data…
Loading stock data…
US$1.34
Get one email when ENVB crosses your level. Checked every 15 minutes during market hours.
▼ -0.02 (-1.47%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
37.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.13
Bullish momentumMACD above its signal line (-0.17).
50-day average
1.83
Price belowShort-term trend reference.
200-day average
3.78
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Enveric Biosciences Inc. is a biotechnology company primarily focused on developing novel small-molecule therapeutics for the treatment of cancer and neurological diseases. By leveraging advanced technologies, the company aims to address unmet medical needs through innovative pharmaceutical approaches. Enveric Biosciences engages in preclinical research that incorporates cutting-edge techniques in medicinal science, focusing particularly on indications with high demand for new therapeutic option…
www.enveric.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-02-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-01-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-12-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-11-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-04-30 | 2.03 | 2.68 | ✓ Beat |
| 2026-02-23 | 1.01 | 0.59 | ✗ Miss |
| 2025-09-23 | 1.23 | 2.36 | ✓ Beat |
| 2025-03-28 | -2.76 | -2.03 | ✓ Beat |
| 2024-11-14 | -93.6 | -43.2 | ✓ Beat |
| 2024-08-12 | -99 | -45 | ✓ Beat |
| 2024-05-15 | -139.5 | -109.8 | ✓ Beat |
| 2024-03-26 | -278.1 | -264.6 | ✓ Beat |
Companies in the same industry, via Finnhub